Delcath Systems
DCTH | NASDAQ
$19.87
-$0.68 (-3.31%)
At close: Nov 16, 2026, 4:00 PM ET
$19.87
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-3.31%
(1D)No price chart data available for 1D timeframe.
Rating
66
+2.0 ptsFundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #82/1021 (Top 8%)
Key Statistics
Market Data
Market Cap $691.24M
1D Range
19.60 20.68
52W Range
8.19 21.77
Valuation (TTM)
PE 124.19
PB 5.18
EV/EBITDA 63.41
Valuation (NTM)
Forward PE 114.17
Forward PEG 0.45
Price Target $28.50
Cash Flow
FCF Yield 2.9%
SBC Adj. FCF Yield 0.2%
SBC Impact -93.5%
Margins
Gross Margin 87.6%
Operating Margin 5.2%
FCF Margin 18.3%
Growth (CAGR)
Revenue 3Y | 5Y 270.3% |
123.9%
Dil EPS 3Y | 5Y 189.2% |
70.4%
FCF 3Y | 5Y 1168.7% |
134.6%
Returns
ROA 4.5%
ROE 5.6%
ROIC 3.1%
Financial Health
Net Cash
$104.32M
Current Ratio 10.87
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investi...
Sector Healthcare
Industry Medical - Devices
Employees 156
IPO Date May 3, 2018
Website www.delcath.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 9, 2026
EPS
$0.17
Beat +285.39%
YoY:
+750.00% REV
$35.1M
Beat +35.04%
YoY:
+70.70%Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$28.50
Upside
+43.43%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove DCTH